- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, September 30, 2022
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by HealthLeaders cited a study published in the September 2022 issue of The American Journal of Managed Care® (AJMC®). In the study, “Insurers Negotiate Lower Hospital Prices for HIX Than for Commercial Groups,” hospital price transparency data suggested that health insurance exchange plans get lower negotiated rates than commercial group plans and higher negotiated rates than Medicare Advantage plans.
Another piece by HealthLeaders spotlighted an article published on AJMC.com, the website of AJMC®. The article covered recent daily news updates, including how nonprofit hospitals pursue profits from low-income patients and an announcement by the Biden administration that $1.5 billion would be set aside to battle opioid overdoses and support recovery.
An article by Digital Health referenced a 2020 study published in a supplement to AJMC®, titled “Economic Burden of Alzheimer Disease and Managed Care Considerations.” The study indicated that health care costs associated with the treatment of Alzheimer disease were an estimated $305 billion in 2020.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
